Pasithea Therapeutics Corp. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| KEPOS CAPITAL LP | 11/12/2024 | 334,600 | $12,000 | 0.00% | 32.05% |
| WARBERG ASSET MANAGEMENT LLC | 11/06/2024 | 263,001 | $9,179 | -5.63% | 25.19% |
| ARMISTICE CAPITAL, LLC | 11/14/2024 | 50,000 | $1,745 | 0.00% | 4.79% |
| CITADEL ADVISORS LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Pasithea Therapeutics Corp.institutional Ownership - FAQ's
During the previous two years, 4 institutional investors and hedge funds held shares of Pasithea Therapeutics Corp.. The most heavily invested institutionals were:
Kepos Capital LP: 334,600
Warberg Asset Management LLC: 263,001
ARMISTICE CAPITAL, LLC: 50,000
CITADEL ADVISORS LLC: 0
62.02% of Pasithea Therapeutics Corp. stock is owned by institutional investors.
Institutional investors have bought a total of 647,601 shares in the last 24 months. This purchase volume represents approximately $19,428 in transactions.